GSK3B and hepatocellular carcinoma: Among these pathways, those involving MAPK/ERK1/2 and AKT/GSK3β have been associated with HCC proliferation (13), while SPHK1 signaling has been associated with the epithelial-to-mesenchymal transition in HCC (37).